DJIA 17,717.52 98.01 0.56%
NASDAQ 5,002.14 15.27 0.31%
S&P 500 2,073.57 10.46 0.51%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

57.56 0.63 (1.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $57.57 1.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $56.93
Previous Close $56.93
Daily Range $56.61 - $57.87
52-Week Range $52.49 - $63.62
Market Cap $162.6B
P/E Ratio 14.86
Dividend (Yield) $1.80 (3.2%)
Ex-Dividend Date
Dividend Pay Date
06/11/15
07/08/15
Volume 6,181,694
Average Daily Volume 9,961,294
Current FY EPS $3.44

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Stocks to Watch in Hep-C Drugs

These are the top hep-C drugmakers vying for share in this multibillion-dollar market.

Dow Analyst Moves: MRK

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Deforestation Impacting Pharmaceutical Industry

Stock Market News for June 30, 2015 - Market News

Has Johnson & Johnson’s Stock Peaked?

Noteworthy ETF Inflows: VHT, PFE, MRK, UNH

Interesting October Stock Options for MRK

Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regime

Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint

Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Zoetis Merger Rumors

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis Merger Rumors

See More MRK News...

MRK's Top Competitors

MRK $57.56 (1.11%)
Current stock: MRK
JNJ $98.42 (0.99%)
Current stock: JNJ
NVS $98.42 (0.08%)
Current stock: NVS
RHHBY $35.05 (-0.07%)
Current stock: RHHBY